Nancy Pelosi and other Demon DemocRATs most saddened!
Trump is announcing guidelines for reopening too.
Probably has more to do with that than one drug.
Great news...in October of 2021 when its maybe approved.
This drug was suggested right from the beginning.
I would like to know how it compares with the far cheaper and more available HCQ.
Wait Gilead! Isn’t that an evil big pharma?
How many Democrat Governors will ban it?!
Boeing is part of it. Surging after hours
Remdesivir...been out there since the beginning of this...
Im hoping this drug along with HCQ/zpack/zinc can be the cure that we need..so many people have died, many didnt have to die, they could have been saved, but it was ALL politics, Trump says give it a try and the Dems say no we need more people to die
Is it one of those bad big pharma companies run by evil white men?
CNBC can shove it. Futures are up on Trump’s press conference.
Follow the money. HCQ is much cheaper but bad because the Orange Man mentioned it. More bs and my bs tank is overflowing
Which politician or funding owns shares in this company?
And they only need to own $32 worth, the New York Times Washington Post daily beast et al went after Donald Trump for puny mutual fund investment.
So how long will it take 327 million people to get to the doctor?
This was the first Med they used on patients. Why is there hype now?
I don’t trust the source here but...
George Soros & Bill Gates Partner with China on Coronavirus Drug!
3/26/2020, 11:58:07 AM · by FR_addict · 72 replies
Civilian Intelligence Network ^ | February 11, 2020 | Shawn Paul Melville
As drug manufacturers speed up their efforts to find a new treatment drug for the coronavirus outbreak that has devastated China and has caused a world-wide panic, a Chinese drug company just announced that it has started mass-producing an experimental drug from Gilead Sciences that has the potential to fight the novel coronavirus (1). BrightGene Bio-Medical Technology, a Suzhou based company (2), just announced that it has developed the technology to synthesize the active pharmaceutical ingredients of Remdesivir, the drug developed by Gilead Biosciences. Its stock price surged 20% in Tuesday morning trading in Shanghai (1). “While BrightGene said that...
Gilead sought and obtained "orphan drug" status for remdesivir from the US Food and Drug Administration on March 23rd, 2020. This provision is intended to encourage the development of drugs affecting fewer than 200,000 Americans by granting strengthened and extended legal monopoly rights to the manufacturer, along with waivers on taxes and government fees.
Remdesivir is a candidate for treating COVID-19; at the time the status was granted, fewer than 200,000 Americans had COVID-19, but numbers were climbing rapidly as the COVID-19 pandemic reached the US, and crossing the threshold soon was considered inevitable. Remdesivir was developed by Gilead with over $79 million in U.S. government funding. After facing strong reactions, Gilead gave up the "orphan drug" status for remdesivir on March 25th. Gilead retains 20-year remdesivir patents in more than 70 countries.
Gilead has also been accused of price-gouging on other medications developed with public funding, including AIDS PrEP drug Tenofovir and hepatitis C drug Sofosbuvir
Is there balm in Gilead?
The market is going to be volatile for awhile. That means that there is money to be made.
Oh no that can’t be!